Saudi Food and Drug Authority and China’s National Medical Products Administration Sign MoU
2024-11-01
In the Chinese capital, Beijing, the Saudi Food and Drug Authority (SFDA) signed a Memorandum of Understanding (MoU) today, Friday, with China’s National Medical Products Administration (NMPA) to exchange experiences and regulatory information.
The MoU was signed by the Chief Executive Officer of the SFDA, H.E. Dr. Hisham S. Aljadhey, and the Commissioner of the NMPA, H.E. Mr. Li Li, at the NMPA headquarters, in the presence of H.E. Mr. Abdulrahman Al-Harbi, Saudi Arabia’s Ambassador to China.